Cell line will be used in vaccine production.

Crucell and Pfizer Animal Health signed  a research license agreement for PER.C6®. The deal allows Pfizer Animal Health to use the cell technology in the production of a undisclosed veterinary vaccine.


Pfizer Animal Health has an option to convert the research license into a commercial agreement.

Previous articleZebrafish as Model Organisms
Next articleSynovics Takes Steps to Enter $600M Market for Omeprazole OTC